ID   TYPK-2
AC   CVCL_4V79
DR   cancercelllines; CVCL_4V79
DR   JCRB; JCRB1708
DR   Wikidata; Q54973478
RX   PubMed=26124327;
CC   Population: Japanese.
CC   Doubling time: 40.4 hours (PubMed=26124327).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=26124327).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1708
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 8,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
RX   PubMed=26124327;
RA   Hirano K., Okumura T., Shimada Y., Watanabe T., Yamaguchi T.,
RA   Nagata T., Tsukada K.;
RT   "Establishment and characterization of two novel human pancreatic
RT   carcinoma cell lines.";
RL   Anticancer Res. 35:3821-3828(2015).
//